Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$12.81
-0.58%
Mkt Cap $904.36M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+196.8%
Consensus $38.00 vs current $12.81
NASDAQ·Healthcare·Biotechnology
$12.81
-0.58%
Mkt Cap $904.36M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+196.8%
Consensus $38.00 vs current $12.81